t
Animalcare Group PLC announced on 6 December 2024 that certain directors subscribed for new Ordinary Shares in a Fundraise on 5 December 2024. Marc Coucke subscribed for 860,215 shares, Jennifer Winter for 32,258 shares, Christopher Brewster for 5,000 shares, and Dr Douglas Hutchens for 5,000 shares. These acquisitions of Ordinary Shares, conducted on the London Stock Exchange - AIM, occurred at a price of 232.5 pence per share for each director.
| Date | 6 Dec 2024 |
| Time | 13:31:06 |
| Category | Director/PDMR dealings |
| ID | 1955P |
ANIMALCARE GROUP PLC
(the "Company")
PDMR Dealing
6 December 2024. Animalcare Group plc (AIM: ANCR), the international animal health business, confirms that following the announcement made on 3 December 2024 regarding a Fundraise, it has received notification that on 5 December 2024 certain directors of the Company have subscribed for new Ordinary Shares in the amounts set out in the table below. In the case of Marc Coucke, Ordinary Shares have been acquired through Alychlo NV, an entity wholly owned by him.
Capitalised terms not defined in this announcement have the meanings given to them in the Fundraise Announcement dated 3 December 2024.
|
|
On the date of this announcement |
|
Immediately following Admission |
||
|
Director |
Number of Ordinary Shares held |
Percentage of Existing Share Capital |
Number of New Ordinary Shares subscribed for in Fundraise |
Number of Ordinary Shares held |
Percentage of Enlarged Share Capital |
|
Marc Coucke1 |
14,751,674 |
24.43 |
860,215 |
15,611,889 |
22.63 |
|
Jennifer Winter |
68,392 |
0.11 |
32,258 |
100,650 |
0.15 |
|
Christopher Brewster |
280,513 |
0.46 |
5,000 |
285,513 |
0.41 |
|
Dr Douglas Hutchens |
- |
- |
5,000 |
5,000 |
0.01 |
1 Marc Coucke's interest is held through Alychlo NV, an entity wholly owned by him.
The following disclosures are made in accordance with the UK Market Abuse Regulation.
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
|
- a) |
Name |
Marc Coucke, Non-Executive Director |
|
2 |
Reason for the notification |
|
|
a) |
Position/status |
See 1(a) above - Mr Coucke is classified as a PDMR of the Company |
|
b) |
Initial notification /Amendment |
Initial Notification |
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) |
Name |
Animalcare Group plc |
|
b) |
LEI |
213800A7XPQ528RMCC72 |
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of 20p each ("Shares") |
|
b) |
Identification code |
GB0032350695 |
|
c) |
Nature of the transaction(s) |
Acquisition of Shares |
|
d) |
Price(s) and volume(s) |
Volume(s):
860,213 Price: 232.5 pence |
|
e) |
Aggregated information
- Aggregated volume
- Price |
N/A Single transaction |
|
f) |
Date of the transaction |
5 December 2024 |
|
g) |
Place of the transaction |
London Stock Exchange - AIM |
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
|
- a) |
Name |
Jennifer Winter |
|
2 |
Reason for the notification |
|
|
a) |
Position/status |
Chief Executive Officer |
|
b) |
Initial notification /Amendment |
Initial Notification |
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) |
Name |
Animalcare Group plc |
|
b) |
LEI |
213800A7XPQ528RMCC72 |
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of 20p each ("Shares") |
|
b) |
Identification code |
GB0032350695 |
|
c) |
Nature of the transaction(s) |
Acquisition of Shares |
|
d) |
Price(s) and volume(s) |
Volume(s):
32,258 Price: 232.5 pence |
|
e) |
Aggregated information
- Aggregated volume
- Price |
N/A Single transaction |
|
f) |
Date of the transaction |
5 December 2024 |
|
g) |
Place of the transaction |
London Stock Exchange - AIM |
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
|
- a) |
Name |
Christopher Brewster |
|
2 |
Reason for the notification |
|
|
a) |
Position/status |
Chief Financial Officer |
|
b) |
Initial notification /Amendment |
Initial Notification |
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) |
Name |
Animalcare Group plc |
|
b) |
LEI |
213800A7XPQ528RMCC72 |
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of 20p each ("Shares") |
|
b) |
Identification code |
GB0032350695 |
|
c) |
Nature of the transaction(s) |
Acquisition of Shares |
|
d) |
Price(s) and volume(s) |
Volume(s):
5,000 Price: 232.5 pence |
|
e) |
Aggregated information
- Aggregated volume
- Price |
N/A Single transaction |
|
f) |
Date of the transaction |
5 December 2024 |
|
g) |
Place of the transaction |
London Stock Exchange - AIM |
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
|
- a) |
Name |
Dr Douglas Hutchens, Non-Executive Director |
|
2 |
Reason for the notification |
|
|
a) |
Position/status |
See 1(a) above - Dr Hutchens is classified as a PDMR of the Company |
|
b) |
Initial notification /Amendment |
Initial Notification |
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) |
Name |
Animalcare Group plc |
|
b) |
LEI |
213800A7XPQ528RMCC72 |
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of 20p each ("Shares") |
|
b) |
Identification code |
GB0032350695 |
|
c) |
Nature of the transaction(s) |
Acquisition of Shares |
|
d) |
Price(s) and volume(s) |
Volume(s):
5,000 Price: 232.5 pence |
|
e) |
Aggregated information
- Aggregated volume
- Price |
N/A Single transaction |
|
f) |
Date of the transaction |
5 December 2024 |
|
g) |
Place of the transaction |
London Stock Exchange - AIM |
Enquiries:
|
Animalcare Group plc |
|
|
Chris Brewster, Chief Financial Officer and Company Secretary |
+44 (0)1904 487 687 |
|
Stifel Nicolaus Europe Limited (Nominated Adviser & Joint Broker) |
+44 (0)20 7710 7600 |
|
Ben Maddison Nicholas Harland Francis North |
|
|
Panmure Liberum (Joint Broker) |
+44 (0)20 7886 2500 |
|
Corporate Finance: Freddy Crossley/Emma Earl Corporate Broking: Rupert Dearden
|
|
About Animalcare
Animalcare Group plc is a UK AIM-listed international development-focused veterinary sales and marketing organisation. Animalcare operates in seven countries and exports to approximately 40 countries in Europe and worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.
For more information about Animalcare, please visit www.animalcaregroup.com